CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
Frontiers | CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
CD38 and Regulation of the Immune Response Cells in Cancer
Simplified diagram representing of the structure of CD38 and its... | Download Scientific Diagram
Impact de CD38 dans la leucémie à tricholeucocytes
Immune evasion and anti-CD38 monoclonal antibody-targeting cells in the... | Download Scientific Diagram
Traitement par anticorps anti-CD38 : perspectives-Figure
CD38-expressing macrophages drive age-related NAD+ decline | Nature Metabolism
CD38 at the junction between prognostic marker and therapeutic target: Trends in Molecular Medicine
CD38 and Regulation of the Immune Response Cells in Cancer
New Strategies for Targeting CD38 in Multiple Myeloma Take Root
Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+ - Roboon - 2021 - Journal of Neurochemistry - Wiley Online Library
Cells | Free Full-Text | Roles of CD38 in the Immune Response to Infection
Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma Immunotherapy | Semantic Scholar
CD38 - Wikipedia
CD38, A Target for Immunotherapeutic Approaches in Cancer
CD38: A Potential Therapeutic Target in Cardiovascular Disease | SpringerLink
Frontiers | Targeting CD38 for acute leukemia
CD38 Inhibitor Program – Ribon Therapeutics
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma: Trends in Cancer
Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents
Frontiers | CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
John Libbey Eurotext - Innovations & Thérapeutiques en Oncologie - Le daratumumab, premier anticorps monoclonal anti-CD38 pour le traitement du myélome multiple
CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells
